Evidence map›Paper›PMID 37048096›Full record

ArticleCells2023

Isolated Peptide from Spider Venom Modulates Dendritic Cells In Vitro: A Possible Application in Oncoimmunotherapy for Glioblastoma.

Felipe Cezar de Mato, Natália Barreto, Gabriel Cordeiro, Jaqueline Munhoz, Amanda Pires Bonfanti, Thomaz A A da Rocha-E-Silva, Rafael Sutti, Priscilla B M Cruz, Livia R Sanches, André Luis Bombeiro and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. GM-CSF Promotes Superior In Vitro Differentiation of MHC IIInternational journal of molecular sciences · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Felipe Cezar de MatoFaculdade de Ciências Farmacêuticas, Universidade Estadual de Campinas (UNICAMP), Campinas 13083-871, SP, Brazil.
Natália BarretoFaculdade de Ciências Farmacêuticas, Universidade Estadual de Campinas (UNICAMP), Campinas 13083-871, SP, Brazil.ORCID 0000-0001-6150-3582
Gabriel CordeiroFaculdade de Ciências Farmacêuticas, Universidade Estadual de Campinas (UNICAMP), Campinas 13083-871, SP, Brazil.
Jaqueline MunhozDepartment of Agricultural, Food and Nutritional Sciences (AFNS), University of Alberta, Edmonton, AB T6G 2R3, Canada.ORCID 0000-0002-3112-3033
Amanda Pires BonfantiFaculdade de Ciências Farmacêuticas, Universidade Estadual de Campinas (UNICAMP), Campinas 13083-871, SP, Brazil.ORCID 0000-0003-0896-0105
Thomaz A A da Rocha-E-SilvaDepartment of Physiological Sciences, Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo 05653-120, SP, Brazil.
Rafael SuttiValer Laboratórios Eireli, São Paulo 13347-633, SP, Brazil.ORCID 0000-0002-5648-2446
Priscilla B M CruzDepartment of Physiological Sciences, Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo 05653-120, SP, Brazil.
Livia R SanchesDepartment of Physiological Sciences, Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo 05653-120, SP, Brazil.
André Luis BombeiroDepartamento de Biologia Estrutural e Funcional, Instituto de Biologia, UNICAMP, Campinas 13083-862, SP, Brazil.ORCID 0000-0003-2303-8127
Ghanbar Mahmoodi ChalbataniDepartment of Immunology, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID 0000-0003-0738-4708
Liana VerinaudDepartamento de Biologia Estrutural e Funcional, Instituto de Biologia, UNICAMP, Campinas 13083-862, SP, Brazil.
Catarina RapôsoFaculdade de Ciências Farmacêuticas, Universidade Estadual de Campinas (UNICAMP), Campinas 13083-871, SP, Brazil.
Universidade Estadual de Campinas (UNICAMP) · BRMayo Clinic in Arizona · USUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dendritic cells (DCs) vaccine is a potential tool for oncoimmunotherapy. However, it is known that this therapeutic strategy has failed in solid tumors, making the development of immunoadjuvants highly relevant. Recently, we demonstrated that

Indexed as

GlioblastomaSpider VenomsAnimalsCell DifferentiationDendritic CellsHumansMaleMiceMice, Inbred C57BLSpider Venomscell therapydendritic cells vaccineglioblastomaimmunoadjuvantPhoneutria nigriventerPnV

Identifiers

PMID37048096
PMCPMC10092987
OpenAlexW4361004014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.